Remarkable Pathological Response to Neoadjuvant Tepotinib in Lung Adenocarcinoma with MET Exon 14 Skipping Mutation: A Case Report.
THORACIC CANCER（2024）
关键词
MET exon 14 skipping mutation,neoadjuvant,non-small cell lung cancer,tepotinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要